Histopathological observations on the activity of diclazuril (Vecoxan) against the endogenous stages of Eimeria crandallis in sheep.
Doses of sporulated oocysts of Eimeria crandallis were administered to 60 housed lambs aged 3-4 weeks that had been raised coccidia-free. Thirty of the lambs were medicated with diclazuril at intervals over a 20-day period post-infection with the remaining lambs serving as untreated controls. Lambs were euthanased between 5 and 22 days post-infection (dpi) and sections of the small intestine and caecum examined histologically. Untreated lambs showed loss of surface epithelial cells and villous atrophy associated with first-generation meronts, crypt destruction and crypt hyperplasia associated with pro-gamont stages. Diclazuril appeared to have a direct effect on several stages of the parasite life cycle, in particular, the large first-generation meront. Indications were that the drug also had an effect on second-generation meronts and gamont stages. Therapeutic benefits of diclazuril treatment appeared greatest when given early in the infection before damage to the intestine occurs although removal of coccidial stages did appear to reduce the pathology of the disease.
Taylor
M A
MA
VLA Veterinary Unit, Central Science Laboratory, Sand Hutton, York YO41 1LZ, UK. mike.taylor@csl.gov.uk
Catchpole
J
J
Marshall
J
J
Marshall
R N
RN
Hoeben
D
D
D000818:Animals; D002432:Cecum / Q000187:drug effects / Q000469:parasitology / Q000473:pathology; D003048:Coccidiosis / Q000188:drug therapy / Q000469:parasitology / Q000473:pathology / Q000662:veterinary*; D003049:Coccidiostats / Q000494:pharmacology / Q000627:therapeutic use*; D004539:Eimeria / Q000187:drug effects* / Q000254:growth & development; D007421:Intestine, Small / Q000187:drug effects / Q000469:parasitology / Q000473:pathology; D009570:Nitriles / Q000494:pharmacology / Q000627:therapeutic use*; D011897:Random Allocation; D012756:Sheep; D012757:Sheep Diseases / Q000188:drug therapy* / Q000469:parasitology / Q000473:pathology; D016896:Treatment Outcome; D014227:Triazines / Q000494:pharmacology / Q000627:therapeutic use*
D003049:Coccidiostats; D009570:Nitriles; D014227:Triazines; C057884:diclazuril